Changjiang Ying (C Ying)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Systematic Review

Cardiovascular Events

Top Venues

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Diabetes, obesity & metabolism

Journal of endocrinological investigation

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Nong Ji, Jinmiao Lu, Leili Gao, Changjiang Ying, Jiao Sun, Jie Han, Wenhua Zhao, Yunming Gao, Kun Wang, Xin Zheng, Daosheng Xie, Juping Ding, Jiahong Zhao, Qiang Yu, Tong Wang
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial. Diabetes, obesity & metabolism (2023)
Q Ma, Z Chen, Y Fang, X Wei, N Wang, X Zhou, S Li, Changjiang Ying
Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study. Journal of endocrinological investigation (2023)
Kai Guo, Qian Zhao, Meng Wang, Yuchun Lu, Meihong Wo, Xiaoyan Zhou, Changjiang Ying
The Scope of HbA1c Variability and Risk of Vascular Complications Among Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Studies. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 54 (2) (2022)
Jin Jin, Guihua Wu, Chengwei Ruan, Hongwei Ling, Xueman Zheng, Changjiang Ying, Ying Zhang
Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma. Journal of clinical laboratory analysis 36 (6) (2022)
Kai Guo, Hongwei Ling, Xiaoyan Zhou, Changjiang Ying
Age Moderates the Impact of TRAbs on Thyroid Hormones and Hepatic Function in Patients with Graves' Disease. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 53 (7) (2021)